IRONWOOD PHARMACEUTICALS INC (IRWD)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 50M 100M 150M Q3 '24: 91.6M Q4 '24: 90.5M Q1 '25: 41.1M Q2 '25: 85.2M Q3 '25: 122.1M Q4 '25: 47.7M Q1 '26: 106.5M Q2 '26: 113M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Gross Profit Quarterly

0 50M 100M 150M Q1 '19: 67.7M Q2 '19: 90.9M Q3 '19: 130.7M Q4 '19: 115.3M Q1 '20: 77.7M Q2 '20: 89.4M Q3 '20: 103.5M Q4 '20: 115.8M Q1 '19 Q2 '19 Q3 '19 Q4 '19 Q1 '20 Q2 '20 Q3 '20 Q4 '20

Revenue minus cost of sales. This filer tags no gross profit of its own..

Operating Income Quarterly

-30M 0 30M 60M 90M Q3 '24: 25.6M Q4 '24: 31.5M Q1 '25: -29.1M Q2 '25: 45.3M Q3 '25: 75.5M Q4 '25: 6.8M Q1 '26: 72.6M Q2 '26: 79.3M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Net Income Quarterly

-40M -20M 0 20M 40M 60M Q3 '24: 3.6M Q4 '24: 2.3M Q1 '25: -37.4M Q2 '25: 23.6M Q3 '25: 40.1M Q4 '25: -2.3M Q1 '26: 40.8M Q2 '26: 51.3M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Cost of Revenue Quarterly

0 4M 8M 12M Q1 '19: 1M Q2 '19: 11.3M Q3 '19: 506K Q4 '19: 11M Q1 '20: 2.2M Q2 '20: 0 Q3 '20: 0 Q4 '20: 897K Q1 '19 Q2 '19 Q3 '19 Q4 '19 Q1 '20 Q2 '20 Q3 '20 Q4 '20

Operating Cash Flow Quarterly

-30M 0 30M 60M 90M Q3 '24: 9.9M Q4 '24: 15.2M Q1 '25: 20M Q2 '25: -15.1M Q3 '25: 47.6M Q4 '25: 74.6M Q1 '26: 5.1M Q2 '26: 58.3M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Free Cash Flow Quarterly

-30M 0 30M 60M 90M Q1 '24: 44.9M Q2 '24: 33.4M Q3 '24: 9.9M Q4 '24: 15.2M Q1 '25: 19.9M Q2 '25: -15.1M Q3 '25: 47.6M Q4 '25: 74.6M Q1 '24 Q2 '24 Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 70M 140M 210M Q1 '24: 157.7M Q2 '24: 159M Q3 '24: 160.2M Q1 '25: 161M Q2 '25: 176.8M Q3 '25: 177.8M Q1 '26: 166.7M Q2 '26: 167.2M Q1 '24 Q2 '24 Q3 '24 Q1 '25 Q2 '25 Q3 '25 Q1 '26 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-0.30 0.00 0.30 0.60 0.90 Q3 '24: -0.03 Q4 '24: -0.01 Q1 '25: -0.21 Q2 '25: -0.06 Q3 '25: 0.15 Q4 '25: 0.13 Q1 '26: 0.60 Q2 '26: 0.77 Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.